Avalon Ventures XI, L.P. - Jun 15, 2021 Form 4 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
10%+ Owner
Signature
Avalon Ventures XI, L.P. By: Avalon Ventures XI GP, LLC, its general partner, By /s/ Tighe Reardon, Authorized Signatory
Stock symbol
JANX
Transactions as of
Jun 15, 2021
Transactions value $
$10,699,987
Form type
4
Date filed
6/16/2021, 05:59 PM
Previous filing
Jun 10, 2021
Next filing
Nov 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JANX Common Stock Conversion of derivative security +1.14M +592.59% 1.33M Jun 15, 2021 Direct F1, F2
transaction JANX Common Stock Conversion of derivative security +2.38M +179% 3.71M Jun 15, 2021 Direct F1, F2
transaction JANX Common Stock Conversion of derivative security +674K +18.16% 4.39M Jun 15, 2021 Direct F1, F2
transaction JANX Common Stock Conversion of derivative security +2.7M 2.7M Jun 15, 2021 See footnote F1, F3
transaction JANX Common Stock Conversion of derivative security +1.15M +42.76% 3.85M Jun 15, 2021 See footnote F1, F3
transaction JANX Common Stock Purchase $10.7M +629K +16.35% $17.00 4.48M Jun 15, 2021 See footnote F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JANX Series Seed Convertible Preferred Stock Conversion of derivative security -889K -100% 0 Jun 15, 2021 Common Stock 1.14M Direct F1, F2
transaction JANX Series Seed 2 Convertible Preferred Stock Conversion of derivative security -1.86M -100% 0 Jun 15, 2021 Common Stock 2.38M Direct F1, F2
transaction JANX Series A Convertible Preferred Stock Conversion of derivative security -526K -100% 0 Jun 15, 2021 Common Stock 674K Direct F1, F2
transaction JANX Series A Convertible Preferred Stock Conversion of derivative security -2.11M -100% 0 Jun 15, 2021 Common Stock 2.7M See footnote F1, F3
transaction JANX Series B Convertible Preferred Stock Conversion of derivative security -900K -100% 0 Jun 15, 2021 Common Stock 1.15M See footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series Seed Convertible Preferred Stock, Series Seed 2 Convertible Preferred Stock, Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") converted into 1.281 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
F2 The shares are directly held by Avalon Ventures XI, L.P. (Avalon Ventures). Avalon Ventures XI GP LLC (Avalon XI GP) is general partner of Avalon Ventures and may be deemed to have voting and investment power with respect to the shares held by Avalon Ventures. Kevin Kinsella, Richard Levandov, Braden Bohrmann and Jay Lichter, Ph.D. are managing members of Avalon XI GP. Mr. Kinsella, Mr. Levandov, Mr. Bohrmann and Dr. Lichter share voting and investment power with respect to the shares held by Avalon Ventures. Each of such individuals disclaims beneficial ownership of all shares held by Avalon Ventures except to the extent of each such individual's actual pecuniary interest therein, if any.
F3 The shares are directly held by Avalon BioVentures SPV I, LP (ABV SPV). ABV SPV I GP LLC (ABV GP) is a general partner of ABV SPV and may be deemed to have voting and investment power with respect to the shares held by ABV SPV and as a result may be deemed to have beneficial ownership of such shares. Dr. Lichter and Tighe Reardon share voting and investment power with respect to the shares held by ABV SPV. Each of such individuals disclaims beneficial ownership of all shares held by ABV SPV except to the extent of each such individual's actual pecuniary interest therein, if any.
F4 The shares were purchased in the Issuer's initial public offering.